Full-year 2024 revenue guidance was increased, reflecting high growth expectations. Inari Medical reported strong revenue growth in its third-quarter 2024 earnings but faced a net loss due to ...

Inari Medical (NASDAQ:NARI) will release its quarterly earnings report on Monday, 2024-10-28. Here's a brief overview for investors ahead of the announcement. Analysts anticipate Inari Medical to ...

Increased our position in Inari Medical, Inc. due to attractive valuations for a market-leading medical device company. Inari dominates the PE market and has significant growth opportunities in ...

Inari, a technology solution provider for global insurance and reinsurance companies, has partnered with Diesta, which offers streamlined premium processing platforms for insurance intermediaries.

Forbes does not accept payment for placement on lists.

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

The Snakemake Wrapper Repository is a collection of reusable wrappers that allow to quickly use popular command line tools from Snakemake rules and workflows.

Analysts' ratings for Inari Medical (NASDAQ:NARI) over the last quarter vary from bullish to bearish, as provided by 8 analysts. The table below summarizes their recent ratings, showcasing the ...

In Malaysia, one key company in that supply chain is Inari Amertron Bhd, a company with a RM10bil market capitalisation, operating as a outsourced semiconductor assembly and test (OSAT ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

If you’re on the fence about investing in Inari Medical, Inc., Penumbra or Inc. because you’re not sure how they measure up, it’s important to compare them on a few factors before making your decision ...